Videos

Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain/media/en/gui/28704/report.html
Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth
Tell them on facebook: https://www.facebook.com/jnj/
Tell them on instagram: https://www.instagram.com/jnj/?hl=en
And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.
Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents. Thank you for joining in this fight. -John Green